Evidence map›Paper›PMID 42862143›Full record

ArticleActa dermato-venereologica2026

OX40/OX40L Inhibitors in Atopic Dermatitis: Current Evidence on Short-term Safety.

Kian Karimian, Daniel Isufi, Mikkel Bak Jensen, Raj Chovatiya, Christopher G Bunick, Tiago Torres, Jakob Ferløv Baselius Schwensen, Nikolai Loft

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta dermato-venereologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kian KarimianNational Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Herlev, Denmark.
Daniel IsufiDepartment of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Hellerup, Denmark.
Mikkel Bak JensenNational Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Herlev, Denmark; Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Raj ChovatiyaDepartment of Medicine, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, United States; Center for Medical Dermatology and Immunology Research, Chicago, IL, USA, United States.
Christopher G BunickDepartment of Dermatology, Yale School of Medicine, New Haven, CT, United States; Program in Translational Biomedicine, Yale School of Medicine, New Haven, CT, United States.
Tiago TorresDepartment of Dermatology, Centro Académico Clínico ICBAS/Santo António, Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
Jakob Ferløv Baselius SchwensenNational Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Herlev, Denmark; Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Nikolai LoftDepartment of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Hellerup, Denmark. nikolai.nguyen.loft@regionh.dk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42862143
PMCPMC13656841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.